SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 1,075-2.6%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron Flanigan who wrote (187)4/28/1998 11:15:00 PM
From: Anthony Wong  Read Replies (1) of 641
 
Eli Lilly & Co. Reinstated 'Strong Buy' at Aros Securities
[old news, but I am posting it here just for the record]

Bloomberg News
April 24, 1998, 7:52 a.m. PT

Princeton, New Jersey, April 24 (Bloomberg) -- Eli Lilly & Co. (LLY US) was reinstated ''strong buy'' by analysts Tim O'Reilly and Henrik D. Simonsen at Aros Securities Inc. The 12-month target price is $90.00 per share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News